| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5502464 | Journal of the Neurological Sciences | 2017 | 6 Pages |
Abstract
Our results suggest that NEDA at 1Â year could be used to predict long term outcome after initiation of DMT in CIS. For non-NEDA patients, monitoring SDMT and brain atrophy could be potentially relevant, but this should be confirmed on a larger sample.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Mikael Cohen, Bruno Brochet, Pierre Clavelou, Emmanuelle Le Page, Patrick Vermersch, Ayman Tourbah, Thibault Moreau, Héloïse Joly, Charlotte Sakarovitch, Christine Lebrun, Qualicis Study Group Qualicis Study Group,